Dr. John Strobeck Scholarship for Future Doctors Offers $1,000 to Support Aspiring Medical Professionals
October 09, 2023 12:05 ET
|
Dr John Strobeck Scholarship
NEW MILFORD, N.J., Oct. 09, 2023 (GLOBE NEWSWIRE) -- Future doctors in the United States have a unique opportunity to further their medical education and contribute to healthcare innovation with the...
Dr. John Strobeck Scholarship for Future Doctors Announces Funding for Medical Students
May 01, 2023 10:12 ET
|
Dr John Strobeck Scholarship
NEW MILFORD, N.J., May 01, 2023 (GLOBE NEWSWIRE) -- The Dr. John Strobeck Scholarship for Future Doctors is pleased to announce its inaugural scholarship program. The scholarship is a one-time award...
Daxor’s Blood Volume (BVA-100®) Diagnostic Demonstrates Clinical Utility In Critically-Ill COVID-19 Patients In Newly Published Data in Journal Critical Care
August 04, 2021 08:30 ET
|
Daxor Corporation
Data Led to Multi-Center Study In Progress At Three Leading Hospitals Oak Ridge, TN, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume...
Daxor Corporation Receives National Institutes of Health (NIH) Funding Notification for Landmark Multi-Center Heart Failure Trial Utilizing the BVA-100® (Blood Volume Analyzer) with the United States Department of Veterans Affairs
May 06, 2021 08:30 ET
|
Daxor Corporation
NEW YORK, May 06, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, today announces the initiation of a multi-center clinical...
Newly Published Study Demonstrates Clinical Utility of Daxor’s Blood Volume (BVA-100®) Diagnostic in the Assessment of Postural Tachycardia Syndrome (POTS)
April 29, 2021 08:31 ET
|
Daxor Corporation
NEW YORK, April 29, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, today announces new data demonstrating the clinical utility...
Daxor Corporation Announces $0.48 Per Share NAV Increase and Files Annual Report for Fiscal 2020
February 26, 2021 08:30 ET
|
Daxor Corporation
Revenues of Operating Division Increase by 50.4% NEW YORK, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) The global leader in blood volume technology today filed its Annual...
Daxor Corporation Announces Pricing of $7.0 Million Registered Direct Offering
July 20, 2020 09:09 ET
|
Daxor Corporation
NEW YORK, July 20, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE American: DXR) (“Daxor” or the “Company”), an investment company with innovative medical instrumentation and biotechnology...
Second Heart Failure Study From the Mayo Clinic Utilizing Daxor's BVA-100 Blood Volume Analyzer Published in Journal of Cardiovascular Trans. Res. (2015) 8:404-410
November 25, 2015 09:00 ET
|
Daxor Corp.
STATEN ISLAND, NY--(Marketwired - Nov 25, 2015) - Daxor Corp. (NYSE MKT: DXR) -- A study from the Mayo Clinic by Wayne L. Miller, MD, PhD. and Brian P. Mullan, MD, involved 32 patients admitted for...
Daxor Corporation Appoints Michael Feldschuh as Executive Vice President
December 18, 2014 08:30 ET
|
Daxor Corp.
NEW YORK, NY--(Marketwired - Dec 18, 2014) - Daxor Corp (NYSE MKT: DXR) announced today that it has appointed Michael Feldschuh as Executive Vice President, to head business development...
Telesphere's Indirect Channel Program Experiencing Record-Breaking Growth Due to Automation and Channel Support Alignment
September 11, 2014 13:16 ET
|
Telesphere
SCOTTSDALE, Ariz., Sept. 11, 2014 (GLOBE NEWSWIRE) -- Telesphere, the nation's leading provider of fully hosted VoIP and unified cloud communications services for businesses, has ramped up its Channel...